Close Menu

Abbott

The UCSF Viral Diagnostics and Discovery Center, located near the school's Mission Bay, Calif., campus, will use the ViroChip pathogen-identification and screening tool as its "core technology."

The UCSF Viral Diagnostics and Discovery Center will use sequencing, microarrays, and other genomic technologies to characterize pathogens linked to acute and chronic human illnesses.

The suit revolves around patents owned by UNeMed, the technology-transfer organization for the UN Medical Center, and exclusively licensed to Abbot Laboratories, though Abbott is not listed as a co-plaintiff on the complaint.

The California District court denied motions for summary judgment of invalidity of Abbott's in situ DNA hybridization patent.

LGC will develop clinical and non-clinical applications for the Ibis T5000 Biosensor System.

Snippets: Apr 1, 2009

Premium

Epigenomics, Response Genetics, Exact Sciences

Shaun Lonergan

Paired Ends: Mar 10, 2009

Premium

Kevin Ulmer, Patrick Soon-Shiong, Shaun Lonergan

William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.

Pages

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.